GlaxoSmithKline: head of vaccines unit to leave
(CercleFinance.com) - GlaxoSmithKline has said that the head of its vaccines unit, Luc Debruyne, will leave the company at the end of the year after a 27-year career at GSK.
Roger Connor, who is currently head of global manufacturing and supply (GMS), will become head of the vaccines division on 1 September, the drugmaker said.
For the last five years Luc Debruyne has been responsible, amongst other things, for the integration of the Novartis vaccines business.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
Roger Connor, who is currently head of global manufacturing and supply (GMS), will become head of the vaccines division on 1 September, the drugmaker said.
For the last five years Luc Debruyne has been responsible, amongst other things, for the integration of the Novartis vaccines business.
Copyright (c) 2018 CercleFinance.com. All rights reserved.